Cardiovascular Profile Score and Perinatal Survival Among Fetuses With Ebstein’s Anomaly or Tricuspid Valve Dysplasia: A Multi‐Center Retrospective Cohort Study
Prenatal Diagnosis · 2026
DOI: 10.1002/pd.70071 ↗At a glance
Multizentrische Studie in Prenatal Diagnosis, 2026. Written by Grace Freire and 13 co-authors. Institution: Perinatal Cardiology, All Children's Hospital, Johns Hopkins Medicine, St Petersburg, Florida, USA. Major MEDLINE topics: Ebstein Anomaly, Tricuspid Valve, Tricuspid Valve Insufficiency. 17 references. Funded by: Johns Hopkins All Children's Foundation.
Abstract (original language)
Objective
We sought to perform multi‐variable modeling to assess the independent value of the CVPS in fetuses with Ebstein anomaly or tricuspid valve dysplasia (EA/TVD).
Methods
CVPS was assessed at a core lab using the first and last echocardiograms during gestation. A receiver operating characteristic (ROC) curve analysis was conducted. Changes in the CVPS from the first to the last echo were assessed with Wilcoxon signed‐rank tests.
Results
There were 164 fetuses with EA/TVD with complete CVPS at the first echo. Nearly half, 48.8% ( n = 80), had intrauterine fetal demise (IUFD) or died neonatally. At the first echo, median gestational age (GA) was 27.6 weeks (IQR: 23.0–31.0) and median CVPS was 7 (IQR: 6–8). The optimal cut‐point for classification of perinatal survival was observed at CVPS ≥ 6.5 (Youden index = 0.46). After adjustment, there remained a significant independent association between every 1‐point increase in the CVPS at first echo and the odds of perinatal survival (adjusted odds ratio: 2.0, 95% CI: 1.3 to 3.2, and p = 0.003). The CVPS at the last echo decreased by a median of 1 point among both survivors ( p < 0.01) and non‐survivors ( p < 0.001).
Conclusion
Among fetuses with EA/TVD, the CVPS may be used as an additional tool to assess perinatal survival throughout gestation.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Perinatal Cardiology, All Children's Hospital, Johns Hopkins Medicine, St Petersburg, Florida, USA.
- Nemours Children's Hospital, Orlando, Florida, USA.
- Department of Cardiology, Hospital Sant Joan de Deu, Barcelona, Spain.
- Department of Pediatrics and Division of Cardiology, Cleveland Clinic Children's Hospital, Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio, USA.
- Department of Pediatrics, Division of Cardiology, Seattle Children's Hospital, University of Washington School of Medicine, Seattle, Washington, USA.
- Department of Pediatrics, Division of Cardiology, Children's Medical Center, University of Texas Southwestern Medical School, Dallas, Texas, USA.
ORCID profiles: Grace Freire, Rukmini Komarlu, Wayne Tworetzky
Funding
- Johns Hopkins All Children's Foundation
Cite
APA
Freire, G., Thieu, N., Diaz, M. E., Komarlu, R., Vernon, M. M., Ikemba, C. M., Michelfelder, E. C., Samai, C., Kovalchin, J. P., Tworetzky, W., Huhta, J., Wilhm, M., Fierstein, J. L., & Freud, L. R. (2026). Cardiovascular Profile Score and Perinatal Survival Among Fetuses With Ebstein’s Anomaly or Tricuspid Valve Dysplasia: A Multi‐Center Retrospective Cohort Study. Prenatal Diagnosis. https://doi.org/10.1002/pd.70071
Vancouver
Freire G, Thieu N, Diaz ME, Komarlu R, Vernon MM, Ikemba CM, et al. Cardiovascular Profile Score and Perinatal Survival Among Fetuses With Ebstein’s Anomaly or Tricuspid Valve Dysplasia: A Multi‐Center Retrospective Cohort Study. Prenatal Diagnosis. 2026. doi:10.1002/pd.70071
BibTeX
@article{Freire2026,
author = {Freire, Grace and Thieu, Nguyen and Diaz, Maria Escobar and Komarlu, Rukmini and Vernon, Margaret M and Ikemba, Catherine M and Michelfelder, Erik C and Samai, Cyrus and Kovalchin, John P and Tworetzky, Wayne and Huhta, James and Wilhm, Marilyn and Fierstein, Jamie L and Freud, Lindsay R},
title = {Cardiovascular Profile Score and Perinatal Survival Among Fetuses With Ebstein’s Anomaly or Tricuspid Valve Dysplasia: A Multi‐Center Retrospective Cohort Study},
journal = {Prenatal Diagnosis},
year = {2026},
doi = {10.1002/pd.70071}
}
EUVIMED